KR
55
-2
VRSK
61
-2
ABT
69
-5
PWR
41
-2
K
65
2
OI
34
-3
MMM
49
2
KLAC
61
-2
DOW
36
2
RCL
76
3
CVS
70
-2
JBHT
50
5
LOW
45
2
VZ
40
-2
GLW
52
3
LEG
37
6
AKAM
37
2
PM
68
2
NTAP
54
2
PRGO
37
-3
KR
55
-2
VRSK
61
-2
ABT
69
-5
PWR
41
-2
K
65
2
OI
34
-3
MMM
49
2
KLAC
61
-2
DOW
36
2
RCL
76
3
CVS
70
-2
JBHT
50
5
LOW
45
2
VZ
40
-2
GLW
52
3
LEG
37
6
AKAM
37
2
PM
68
2
NTAP
54
2
PRGO
37
-3
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

Apple's Space Move Could Send This Pre-IPO Stock Soaring

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

HQL
abrdn Life Sciences Investors

Last Price:
$14.00
Seasonality Move:
-1.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Attention Investors: The 10 Best stocks for 2025 - yours FREE

Get Your Copy of "10 Best Stocks to Own in 2025" Here.

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.8% based on the past 27 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $13.99. The Score for HQL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 4.8% based on the past 27 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
40
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
12.76

Prediction Charts

Market Cap:
0
Price in USD:
13.99
Volume:
99.7K
Beta:
0.95

Technical Analysis

SMA50:
13.80
SMA100:
14.29
SMA200:
14.42
52-Wk Change:
0.14%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 13.99 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-28 14.14 14.11 14.24 14.10
Jan-29 14.12 14.13 14.20 14.01
Jan-30 14.20 14.16 14.27 14.02
Jan-31 14.22 14.21 14.33 14.19
Feb-3 14.06 14.02 14.10 13.93
Feb-4 14.01 14.03 14.10 13.93
Feb-5 14.20 14.36 14.36 14.09
Feb-6 14.41 14.27 14.42 14.22
Feb-7 14.26 14.03 14.29 13.98
Feb-10 14.05 13.94 14.07 13.88
Feb-11 13.91 13.77 13.92 13.73
Feb-12 13.75 13.80 13.80 13.66
Feb-13 13.91 13.96 13.98 13.75
Feb-14 14.02 13.99 14.21 13.98

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.